Development of oligonucleotide therapeutics based on the molecular functions of FUS and tau.
We are developing oligonucleotide therapeutics for FTLD spectrum disorders by regulating the metabolism of FUS and tau in neurons.
We are developing oligonucleotide therapeutics for FTLD spectrum disorders by regulating the metabolism of FUS and tau in neurons.